When tested in mice, a vaccine candidate generated a surge of antibodies against SARS-CoV-2 within two weeks of the microneedle prick. University of Pittsburgh School of Medicine scientists say this is the first study to be published after critique from fellow scientists at outside institutions that describes a candidate vaccine...